Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-08 Sale |
2021-02-10 7:07 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
56,159 | $23.05 | $1,294,534 | 1,192,545 (Indirect Direct) |
View |
| 2021-02-03 Sale |
2021-02-05 6:55 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
2,477 | $22.09 | $54,717 | 411,680 (Direct) |
View |
| 2020-10-09 Sale |
2020-10-14 5:22 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
251,572 | $21.02 | $5,288,013 | 1,077,457 (Indirect Direct) |
View |
| 2020-07-01 Sale |
2020-07-02 4:13 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
29,589 | $25.37 | $750,678 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-09-02 Option Award |
2021-09-07 5:15 pm |
N/A 2031-09-01 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. Chief Medical Officer |
48,300 | $0 | 48,300 (Direct) |
View |
| 2021-09-02 Option Award |
2021-09-07 5:14 pm |
N/A 2031-09-01 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
183,934 | $0 | 183,934 (Direct) |
View |
| 2021-06-29 Option Award |
2021-07-01 4:08 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
66,474 | $0 | 66,474 (Indirect) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:22 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | McCain Tracey L Director |
33,237 | $0 | 33,237 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:22 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Popovits Kimberly J Director |
33,237 | $0 | 33,237 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:21 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Malley Thomas Director |
33,237 | $0 | 33,237 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:20 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director |
33,237 | $0 | 33,237 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:20 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director |
33,237 | $0 | 33,237 (Direct) |
View |
| 2021-06-29 Option Award |
2021-06-30 4:20 pm |
N/A 2031-06-28 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director |
33,237 | $0 | 33,237 (Direct) |
View |
Ownership |
2021-06-21 5:37 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Pano Arian Chief Clinical Dev. Officer |
0 | $0 | 196,859 (Direct) |
View |
Ownership |
2021-06-21 5:37 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Tessari Eben Chief Business Officer |
0 | $0 | 622,046 (Direct) |
View |
| 2021-04-26 Option Award |
2021-04-28 5:31 pm |
N/A 2031-04-25 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO |
27,687 | $0 | 27,687 (Direct) |
View |
Ownership |
2021-04-15 5:32 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Moat Ross Group VP & Rilonacept GM |
0 | $0 | 109,720 (Direct) |
View |
| 2021-03-20 Option Award |
2021-03-23 5:35 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO |
5,177 | $0 | 5,177 (Direct) |
View |
| 2021-03-20 Option Award |
2021-03-23 5:35 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer |
9,347 | $0 | 9,347 (Direct) |
View |
| 2021-03-20 Option Award |
2021-03-23 5:34 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R Chief Accounting Officer |
5,394 | $0 | 5,394 (Direct) |
View |
| 2021-03-20 Option Award |
2021-03-23 5:33 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
30,557 | $0 | 30,557 (Direct) |
View |
| 2021-03-20 Option Award |
2021-03-23 5:32 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
10,142 | $0 | 10,142 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:14 pm |
N/A 2031-03-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark CFO |
24,413 | $0 | 24,413 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:12 pm |
N/A 2031-03-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R Chief Accounting Officer |
9,293 | $0 | 9,293 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:12 pm |
N/A 2031-03-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer |
48,300 | $0 | 48,300 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:10 pm |
N/A 2031-03-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
183,934 | $0 | 183,934 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:07 pm |
N/A 2031-03-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
61,380 | $0 | 61,380 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 7:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
26,925 | $1.59 | 1,192,545 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 7:07 pm |
N/A 2025-12-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
26,925 | $0 | 1,192,545 (Direct) |
View |
| 2021-02-03 Conversion |
2021-02-05 6:55 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
300,000 | $0 | 411,680 (Direct) |
View |
| 2020-12-31 Exercise |
2021-01-05 5:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Interim CFO |
4,404 | $0 | 3,107 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 5:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Interim CFO |
1,297 | $17.67 | 3,107 (Direct) |
View |
| 2020-12-31 Exercise |
2021-01-05 5:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer |
7,337 | $0 | 5,176 (Direct) |
View |
| 2020-12-31 Tax Withholding |
2021-01-05 5:07 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer |
2,161 | $17.67 | 5,176 (Direct) |
View |
Ownership |
2020-12-23 5:03 pm |
N/A 2028-05-22 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Ragosa Mark Interim CFO |
0 | $0 | 108,703 (Direct) |
View |
| 2020-10-09 Exercise |
2020-10-14 5:22 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
151,572 | $1.59 | 1,077,457 (Direct) |
View |
| 2020-10-09 Exercise |
2020-10-14 5:22 pm |
N/A 2025-12-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
151,572 | $0 | 1,077,457 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 5:16 pm |
N/A 2030-09-09 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Patel Sanj K Chairman & CEO |
180,000 | $0 | 180,000 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 5:14 pm |
N/A 2030-09-09 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 5:12 pm |
N/A 2030-09-09 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Paolini John F. SVP & Chief Medical Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 5:09 pm |
N/A 2030-09-09 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Rizvi Qasim Chief Commercial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 5:06 pm |
N/A 2030-09-09 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Megna Michael R Chief Accounting Officer |
19,000 | $0 | 19,000 (Direct) |
View |
| 2020-07-27 Option Award |
2020-07-29 5:46 pm |
N/A 2030-07-26 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Cole G Bradley Director |
37,965 | $0 | 37,965 (Direct) |
View |
| 2020-07-24 Option Award |
2020-07-28 5:32 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
1,428,572 | $21 | 12,781,964 (Indirect) |
View |
| 2020-06-30 Option Award |
2020-07-02 5:53 pm |
N/A 2030-06-30 |
Kiniksa Pharmaceuticals Ltd. | KNSA | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
37,520 | $0 | 37,520 (Indirect) |
View |
| 2020-06-30 Option Award |
2020-07-02 4:14 pm |
N/A 2030-06-29 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Levy Richard S Director |
18,760 | $0 | 18,760 (Direct) |
View |